about
Propranolol for the treatment of anxiety disorders: Systematic review and meta-analysisMechanisms of altered Ca²⁺ handling in heart failureComparison of the haemodynamic effects of bucindolol, propranolol and pindolol in healthy volunteersLymphovascular and neural regulation of metastasis: shared tumour signalling pathways and novel therapeutic approaches.G protein-coupled receptors in cardiac biology: old and new receptorsEffects of beta-adrenergic blockade on the cardiac response to maximal and submaximal exercise in man.Effects of exercise on myocardial force-velocity relations in intact unanesthetized man: relative roles of changes in heart rate, sympathetic activity, and ventricular dimensionsEffects of beta-adrenergic receptor blockade in normal subjects before, during, and after triiodothyronine-induced hypermetabolism.Reflections on drug researchSelective beta-1 receptor blockade with oral practolol in man. A dose-related phenomenon.Improved physical performance as a therapeutic objective in patients with angina.Anesthetic considerations for thoracoscopic sympathetic ganglionectomy to treat ventricular tachycardia storm: a single-center experienceEnzyme secretion in mouse pancreas mediated by adenosine-3'5'-cyclic phosphate and inhibited by adenosine-3'-phosphate.Preoperative treatment of thyrotoxicosis in developing countries: a comparative study of carbimazole and propranolol.Comparison of some properties of pronethalol and propranolol. 1965Comparison of some properties of pronethalol and propranolol.Action of propranolol on the atrioventricular node and on its response to adrenaline and isoprenaline.A comparison of the effects of locally and systemically administered kinins on coronary blood flow and myocardial metabolism.Dimethyl isopropylmethoxamine: a selective beta-receptor blocking agentEffect of propranolol on alpha-adrenergic blockade in the dog and isolated rabbit aortic stripModifications by propranolol of the response of isolated rabbit atria to endogenous and exogenous noradrenaline.1-Isopropylamino-3-(4-indanoxy)-2-propanol HC1: a potent beta-adrenoreceptor antagonist.A comparison of the anti-arrhythmic actions of I.C.I. 50172 and (--)-propranolol and their effects on intracellular cardiac action potentials and other features of cardiac function.THE USE OF SYMPATHETIC BETA-RECEPTOR BLOCKING AGENTS IN THE INVESTIGATION OF REFLEX CHANGES IN HEART RATE.The beta-adrenoceptor blocking properties of the alpha-methyl analogues of propranolol and practolol in the anaesthetized dogMassive phaeochromocytoma.Intravenous propranolol for cardiac disturbances in relation to halothane anesthesia for cardiovascular surgery.An adrenergic control system in TetrahymenaEffects of hydrocortisone on acute β-adrenoceptor blocker and histamine induced bronchoconstriction.Conversion of atrial fibrillation and flutter by propranolol.Modification of cardiovascular responses by propranolol.Systemic circulatory response to stress of simulated flight and to physical exercise before and after propranolol blockade.Effects of propranolol on fear of dental extraction: study protocol for a randomized controlled trial.Glucocorticoid receptors recruit the CaMKIIα-BDNF-CREB pathways to mediate memory consolidation.Cardiac output after beta-adrenergic blockade in ischaemic heart disease.β-Adrenergic blockade in cardiovascular disease.Beta-adrenergic antagonists during general anesthesia reduced postoperative pain: a systematic review and a meta-analysis of randomized controlled trials.An on-chip model for investigating the interaction between neurons and cancer cells.S-propranolol protected H9C2 cells from ischemia/reperfusion-induced apoptosis via downregultion of RACK1 Gene.Neprilysin inhibition: A brief review of past pharmacological strategies for heart failure treatment and future directions.
P2860
Q26781133-76CD2EBB-B220-46ED-AD69-E04E05DC3C73Q27012758-83C16B64-69C0-4848-82C1-B32566877225Q28360032-8E456676-64C5-40CF-80F9-0CD00DA9B497Q33555154-A2693C48-4C21-48B8-9635-392896FA0C81Q33639685-43E5DE75-0755-4B10-B038-D8398515C65CQ33960325-EE6CD405-A41C-43DB-89FD-16060C1663BAQ33961892-732FB369-AFC7-4B3D-A003-BC42C9BD244EQ34082627-D272F849-D675-4453-8725-1A6F6A1B94F1Q34399282-721D564C-0814-457E-83B3-DE2E1EC7CB89Q34482030-9E891AED-854A-49AA-983D-1E84F01F2DEEQ34516462-EF18863C-DF67-4C83-A1F4-5B9BE3301AD1Q34617304-E10DFFA5-A484-43C1-B6F7-6079583DA192Q34655905-75F8A584-6D03-4360-ADA7-B926A05D35DFQ34686575-3DCAA4E5-1471-432F-B0C6-59BA0A1080E3Q34740071-8B23DC56-5077-43A2-A5B8-0FC1F36F49D6Q34794060-E641A304-72CA-436A-B9C2-B7B697BB7D88Q34794118-0478D05F-0C48-4606-973D-1FE7152137B6Q34794670-8E928ED9-B843-4A91-BAEF-F6E1FD7C63B6Q34794888-5D30AA12-9CF5-4503-99C3-AD30EAFA78CDQ35011594-AE962141-BFFB-4122-BEBF-1B206B36688CQ35039773-1269FD93-5F2D-46AF-896E-17BE89D3684AQ35226355-B543CB0F-C9AD-4EAC-8A01-7B0371922BECQ35227162-AD7C6876-8424-4D15-BD6A-5DFDFBE11D1FQ35227714-93C66FA7-5733-4DC4-965B-EDD02EBE279CQ35600682-28FF968D-D1D6-47E5-96EE-C0344E8EC09BQ35854412-E6C3C2DF-2300-4781-9D62-B4FF2C2D3CD4Q35900896-5C6D3F1B-517C-43FE-9416-778C18DC8564Q35971673-AA736B56-B67A-425F-A814-A279BB6DB42FQ36111202-526E4571-B51D-4A3A-BEC8-BA73E34E27E0Q36114610-C37EFFCB-797B-44AE-A13B-AB8B19AA4044Q36114638-C6739146-2851-49EA-9B4F-553262F4AE30Q36115653-AA801652-28FC-4542-BA2F-00E7E6EF81E3Q36321852-3E4B4D82-23DE-4FED-AC24-3974E1864F5DQ36431262-91C8532F-7ED1-4BB3-AE60-7B09C0BA2E7FQ36990357-E1DAB133-A997-473F-B8B8-BB4298CC3B69Q38103516-8915E335-409F-4A85-8C5F-B7C93B04D989Q38544704-49DCBB25-147C-49E7-8343-2E26FA4EF606Q38788459-2A7295F7-67E8-4CC3-9804-7E21E9C7C051Q38815889-A5E01092-EC30-407F-9985-3305757279CEQ38817943-F6399ED5-DA34-4C2F-9AAF-D52B932F524A
P2860
description
1964 nî lūn-bûn
@nan
1964 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
1964 թվականի մայիսին հրատարակված գիտական հոդված
@hy
1964年の論文
@ja
1964年論文
@yue
1964年論文
@zh-hant
1964年論文
@zh-hk
1964年論文
@zh-mo
1964年論文
@zh-tw
1964年论文
@wuu
name
A NEW ADRENERGIC BETARECEPTOR ANTAGONIST.
@ast
A NEW ADRENERGIC BETARECEPTOR ANTAGONIST.
@en
type
label
A NEW ADRENERGIC BETARECEPTOR ANTAGONIST.
@ast
A NEW ADRENERGIC BETARECEPTOR ANTAGONIST.
@en
prefLabel
A NEW ADRENERGIC BETARECEPTOR ANTAGONIST.
@ast
A NEW ADRENERGIC BETARECEPTOR ANTAGONIST.
@en
P2093
P1433
P1476
A NEW ADRENERGIC BETARECEPTOR ANTAGONIST.
@en
P2093
A C DORNHORST
A F CROWTHER
R G SHANKS
P304
P356
10.1016/S0140-6736(64)91275-9
P407
P577
1964-05-01T00:00:00Z